Thrombolytic therapy streptokinase stimulates breakdown BACKGROUND Plasmin capable extracellular matrix components collagen vitro significance vivo conditions effect streptokinase plasminogen serum concentrations amino-terminal propeptide type III procollagen PIIINP carboxy-terminal propeptide type PICP METHODS RESULTS Twenty-three patients suspected acute myocardial infarction study thrombolytic therapy PIIINP PICP radioimmunoassays Kinetics creatine kinase-MB release reperfusers nonreperfusers Composite curves creatine kinase-MB release different patient subgroups streptokinase infusion serum concentrations PIIINP maximum mean increase micrograms/l minutes similar increase patients thrombolytic therapy myocardial infarction basis enzyme release relative increase PIIINP streptokinase treatment acute myocardial infarction patients probable reperfusion nonprobable reperfusion Corresponding changes PIIINP control group days second increase serum PIIINP patient groups change similar increase PICP CONCLUSIONS streptokinase activation plasminogen breakdown type III collagen thrombolytic therapy phenomenon risk rethrombosis affected artery exposed collagen responsible thrombosis formation development hemorrhagic complications thrombolytic therapy second increase PIIINP levels type III collagen synthesis infarcted area investigation pilot study studies effects various thrombolytic agents interstitial collagen metabolism 